Friday 6 November 2026 Export NBIX’s income statement to Excel — free account

Neurocrine Biosciences, Inc.

NBIX Healthcare Drug Manufacturers Specialty & Generic

Neurocrine Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 21.4% from fiscal 2024.

Revenue: +41.2%
EPS: −3.67%
Free cash flow: +79.0%

Quarter to September 2026, against a year earlier

164.51 4.75 +2.97%

Follow NBIX

Alert me

Market cap: $16.2B
P/E: 23.6×
Fwd P/E: 20.6×
Dividend yield: —
F-score: 7/9
Altman Z: 7.80
Beneish M: −2.64
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	7	7	6	6
ROE Full definition →		16.38%	22.50%	22.09%	20.41%
ROA Full definition →		11.46%	15.56%	15.26%	14.20%
ROIC Full definition →		21.83%	23.58%	15.04%	17.65%
Return on Tangible Assets Full definition →		25.61%	39.44%	82.66%	62.96%
Average Days of Receivables Full definition →		87.64	90.37	95.96	94.39
Free Cash Flow per Share Full definition →		7.52	8.27	8.62	10.23
Free Cash Flow Full definition →		748.70	831.30	870.40	1,039.70
Capital Expenditures Full definition →		(34.00)	(32.40)	(27.70)	(26.10)
Other line items
Cash ROIC Full definition →		15.82%	17.60%	21.32%	22.52%
Accounts Receivable Turnover Full definition →		4.91	4.83	4.55	4.39
Accounts Payable Turnover Full definition →		0.09	0.09	0.11	0.11
Inventory Turnover Full definition →		0.82	0.92	0.86	1.21
Average Days of Payables Full definition →		4,723.98	4,976.10	4,238.93	4,100.26
Days of Inventory on Hand Full definition →		483.40	415.21	546.45	293.51
Tax Rate Full definition →		(0.32)	(0.29)	(0.25)	(0.25)
Research and Development Expense of Revenue Full definition →		35.51%	33.80%	33.52%	33.31%
Selling, General and Administrative Expense of Revenue Full definition →		40.42%	38.62%	40.06%	38.53%
Share Based Compensation of Revenue Full definition →		7.62%	7.17%	6.95%	6.35%
Interest Coverage Full definition →		—	—	92.42	113.73
Operating CF/Net income Full definition →		1.64	1.29	1.27	1.52
Depreciation/Fixed assets Full definition →		0.19	0.19	0.42	0.85
Capex/Depreciation Full definition →		(1.95)	(1.89)	(0.74)	(0.33)
Revenue per Share Full definition →		28.75	30.87	33.41	36.43
Operating CF per Share Full definition →		7.87	8.59	8.89	10.49
Capex per Share Full definition →		(0.34)	(0.32)	(0.27)	(0.26)
Capex to Sales Full definition →		0.01	0.01	0.01	0.01

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly